1 J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer Jun 02, 2025
2 K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients! May 27, 2025
3 Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For May 05, 2025
5 More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy! Apr 17, 2025
6 Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche! Apr 10, 2025
Read More Medical Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma May 12, 2025
Read More Apparatus Angry FDA & CDC: $5 Billion Bivalent Moderna New Crown Vaccine Not As Effective As Monovalent May 16, 2025
Read More Medical New Research: Cracking The Targeted Drug Resistance Puzzle And Eliminating Cancer Cells Before They Evolve! May 26, 2025
Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! May 24, 2025
Read More Disease Sudden Red Spots On Your Skin? Beware Of The "Undead Cancer", Be Alert To These Signs May 30, 2025
Read More Apparatus Fda Accepts Zuranolone's Nda Application And Grants It Priority Review For The Treatment Of Mdd And Pdd May 23, 2025
Read More Medical New Targeted Radiotherapy For "Laser-Like" Precision Treatment Of Refractory Prostate Cancer With Fewer Side Effects! Jun 01, 2025
Read More Apparatus J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer Jun 02, 2025
